MerckMillipore100 99• New SMCxPRO™ technology offers high speed, high sensitivity for single molecule detection

• Meets customer demand for biomarker and novel target discovery and  detection

 

Darmstadt, Germany, April 3, 2017 – Merck, a leading science and technology company, today announced the launch of its newest high-sensitivity detection platform, SMCxPRO™ technology, at the American Association for Cancer Research Annual Meeting in Washington, D.C.

 

The complete Merck News Release can be downloaded at the following link:

http://news.merck.de/N/0/CD12D2EFA4D16902C12580F6005358DB/$File/MerckIntroducesProteinDetection040317.pdf

 

Additional picture(s):

http://news.merck.de/N/0/CD12D2EFA4D16902C12580F6005358DB/$File/SMCxPRO.jpg